| Autor: |
Vishakha V Jain, Omprakash Gupta |
| Jazyk: |
angličtina |
| Rok vydání: |
2013 |
| Předmět: |
|
| Zdroj: |
Journal of Mahatma Gandhi Institute of Medical Sciences, Vol 18, Iss 2, Pp 103-108 (2013) |
| Druh dokumentu: |
article |
| ISSN: |
0971-9903 |
| DOI: |
10.4103/0971-9903.117795 |
| Popis: |
Insulin analogues have revolutionized the treatment of diabetes mellitus, and the advent of newer insulin analogues have provided better glycemic control with lesser incidence of hypoglycemia. Insulin degludec is a second-generation, ultra-long-acting acylated basal insulin analogue that possesses a flat, stable glucose-lowering effect in patients with type 1 or type 2 diabetes mellitus. Findings from clinical trials have demonstrated that new-generation, once-daily basal insulin degludec provides similar A1C control as compared to insulin glargine, both administered as basal-oral therapy or in combination with insulin aspart, with the added benefits of lower rates of hypoglycemia, particularly nocturnal hypoglycemia. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
